Fluid-Attenuated Inversion Recovery Vascular Hyperintensities–Diffusion-Weighted Imaging Mismatch Identifies Acute Stroke Patients Most Likely to Benefit From Recanalization
Abstract
Background and Purpose—
Fluid-attenuated inversion recovery vascular hyperintensities (FVH) beyond the boundaries of diffusion-weighted imaging (DWI) lesion (FVH-DWI mismatch) have been proposed as an alternative to perfusion-weighted imaging (PWI)-DWI mismatch. We aimed to establish whether FVH-DWI mismatch can identify patients most likely to benefit from recanalization.
Methods—
FVH-DWI mismatch was assessed in 164 patients with proximal middle cerebral artery occlusion before intravenous thrombolysis. PWI-DWI mismatch (PWITmax>6sec/DWI>1.8) was assessed in the 104 patients with available PWI data. We tested the associations between 24-hours complete recanalization on magnetic resonance angiography and 3-month favorable outcome (modified Rankin Scale score ≤2), stratified on FVH-DWI (or PWI-DWI) status.
Results—
FVH-DWI mismatch was present in 121/164 (74%) patients and recanalization in 50/164 (30%) patients. The odds ratio for favorable outcome with recanalization was 16.2 (95% confidence interval, 5.7–46.5; P<0.0001) in patients with FVH-DWI mismatch and 2.6 (95% confidence interval, 0.6–12.1; P=0.22) in those without FVH-DWI mismatch (P=0.048 for interaction). Recanalization was associated with favorable outcome in patients with PWI-DWI mismatch (odds ratios, 9.9; 95% confidence interval, 3.1–31.3; P=0.0001) and in patients without PWI-DWI mismatch (odds ratios, 7.0; 95% confidence interval, 1.1–44.1; P=0.047), P=0.76 for interaction.
Conclusion—
The FVH-DWI mismatch may rapidly identify patients with proximal occlusion most likely to benefit from recanalization.
Introduction
Mismatch between perfusion-weighted imaging (PWI) and diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) has been proposed to select patients with acute stroke for recanalization therapy.1 However, this approach requires gadolinium injection and dedicated software and increases scan duration. We have recently proposed an alternative model based on the mismatch between fluid-attenuated inversion recovery (FLAIR) vascular hyperintensities (FVH) and DWI to assess the presence of large penumbra.2 FVH have been reported in 45–100% of stroke patients with intracranial occlusion.3–16 They represent slow retrograde flow in leptomeningeal collaterals,4 which maintain some perfusion distal to the occlusion until revascularization.17 The FVH-DWI mismatch focuses on FVH beyond the boundaries of the cortical DWI lesion, ignoring FVH adjacent to the DWI lesion. Therefore, only the FVH facing tissue at risk of infarct expansion are considered in this definition. Rapidly assessable with the naked eye, this model is simple and reproducible and predicts large PWI-DWI mismatch with excellent sensitivity.2
We hypothesized that complete recanalization after intravenous tissue-type plasminogen activator would be associated with better outcome in patients with, as compared to those without, FVH-DWI mismatch.
Materials and Methods
This retrospective analysis was based on a prospectively collected monocenter registry of patients exclusively treated by intravenous tissue-type plasminogen activator (0.9 mg/kg) for acute ischemic stroke between 2004 and 2014. Inclusion criteria were (1) proximal (M1) middle cerebral artery occlusion, (2) pretreatment and 24-hour follow-up MRI to assess recanalization, and (3) 3-month clinical follow-up, including modified Rankin Scale score. The study was approved by the local Ethics Committee.
Pretreatment and follow-up magnetic resonance were performed on 1.5-T units (General Electric Healthcare) using a standardized protocol.2,18 PWI was included in the pretreament magnetic resonance whenever feasible with no delay, but was not part of follow-up magnetic resonance. FVH were defined as focal, tubular, or serpentine hyperintensities in the subarachnoid space relative to cerebrospinal fluid3 and corresponding to typical arterial course. Axial FLAIR and DWI images were reviewed together, blinded to PWI and clinical data. FVH-DWI mismatch was considered present when FVH extended beyond the boundaries of the cortical DWI lesion, that is, when at least one FVH was facing isointense cortex on DWI (Figure). Pretreatment (DWI1) and follow-up (DWI2) lesions were segmented to compute DWI volumes as detailed elsewhere.18 Hypoperfused tissue defined as time to maximum value of the residue function (Tmax)>6 s was segmented from PWI maps (BrainStat AIF, READY View, GE Healthcare), and PWI-DWI mismatch was defined as Volumehypoperfusion/VolumeDWI1>1.8.1 Pretreatment occlusion and complete recanalization were assessed on magnetic resonance angiography.
FVH-DWI and PWI-DWI mismatch were coded as binary variables. Continuous variables were compared with Student’s t-test or Mann–Whitney U test. Categorical variables were compared using χ2 or Fisher’s exact test, as appropriate. Odds ratios (OR) for 3-month favorable outcome (modified Rankin Scale ≤2) were calculated from 2×2 tables. Analyses were stratified on 24-hours recanalization. Logistic regression analyses were done in the FVH-DWI mismatch group and in the no FVH-DWI mismatch group, with 3-month favorable outcome as the dependent variable and recanalization as the explanatory variable. These analyses were secondarily adjusted on admission National Institutes of Health Stroke Scale score in multivariable logistic models using Firth correction19 to avoid potential overfitting, given the small number of patients without FVH-DWI mismatch but with favorable outcome.20 We tested the potential interaction between FVH-DWI mismatch and recanalization to predict favorable outcome using the Breslow-day test.
Results
One hundred and sixty-four patients (85 men) met the inclusion criteria (median [interquartile range] age 72 years [59–82], admission National Institutes of Health Stroke Scale score 17 [12–21], and 3-month modified Rankin Scale 3 [1–5]). PWI was available in 104/164 (63%) patients. Median time-to-initial MRI, time-to-treatment, and time-to-follow-up MRI were 117 mins [88–148], 153 mins [122–189], and 23 hours [20–27].
121/164 (74%) patients had a FVH-DWI mismatch. Median time-to-initial MRI was slightly shorter in patients with FVH-DWI mismatch than in patients without FVH-DWI mismatch (115 mins [86–142] versus 122 mins [107–149] respectively; P=0.043). PWI-DWI mismatch was present in 72/104 (69%) patients. Agreement between FVH-DWI and PWI-DWI for mismatch classification was 86/104 (83%), with κ=0.58. Seven patients had a PWI-DWI mismatch but no FVH-DWI mismatch, and 11 had no PWI-DWI mismatch but a FVH-DWI mismatch.
In the whole population, complete recanalization occurred in 50/164 (30%) patients and was significantly associated with favorable outcome (OR=8.3; 95% confidence interval [CI], 3.9–17.8; P<0.001).
After stratification for FVH-DWI mismatch status (Table), the association between recanalization and favorable outcome was significant in patients with FVH-DWI mismatch (OR=16.2; 95% CI, 5.7–46.5; P<0.0001), but not in patients with no FVH-DWI mismatch (OR=2.6; 95% CI, 0.6–12.1; P=0.22), P=0.048 for interaction. After adjustment on National Institutes of Health Stroke Scale, the odds ratios for favorable outcome with recanalization were 16.6 (95% CI, 5.2–52.7; P<0.0001) in patients with FVH-DWI mismatch and 6.5 (95% CI, 0.95–44.4; P=0.06) in patients without FVH-DWI mismatch.
FVH-DWI Mismatch (n=121) | No FVH-DWI Mismatch (n=43) | |||||
---|---|---|---|---|---|---|
Complete Recanalization (n=38) | No/Partial Recanalization (n=83) | P Value | Complete Recanalization (n=12) | No/Partial Recanalization (n=31) | P Value | |
Initial NIHSS | 14 [9–18] | 17 [13–21] | 0.01 | 19 [17–24] | 18 [16–21] | 0.22 |
Time from onset to initial MRI, min | 106 [76–152] | 117 [88–139] | 0.79 | 112 [91–153] | 129 [110–181] | 0.16 |
VolumeDWI1, mL | 14 [5–34] | 18 [8–34] | 0.27 | 72 [59–124] | 109 [57–160] | 0.50 |
VolumeDWI2, mL | 19 [9–41] | 44 [21–84] | <0.001 | 100 [76–178] | 169 [102–233] | 0.19 |
VolumeDWI2-DWI1, mL | 4 [0–17] | 26 [6–44] | <0.001 | 25 [0–54] | 50 [21–85] | 0.11 |
3-month mRS ≤2 | 33 (87%) | 24 (29%) | <0.001 | 4 (33%) | 5 (16%) | 0.24 |
Values are median [IQR]. DWI indicates diffusion-weighted imaging; DWI1, pretreatment DWI lesion; DWI2, follow-up (≈24 h after thrombolysis) DWI lesion; FVH, fluid-attenuated inversion recovery vascular hyperintensities; IQR, interquartile range; mRS, modified Rankin Scale; and NIHSS, National Institutes of Health Stroke Scale.
After stratification for PWI-DWI mismatch status, the association between complete recanalization and favorable outcome remained significant in patients with PWI-DWI mismatch (OR=9.9; 95% CI, 3.1–31.3; P=0.0001) and was marginally significant in patients without PWI-DWI mismatch (OR=7.0; 95% CI, 1.1–44.1; P=0.047), P=0.76 for interaction.
Discussion
The present study shows that a simple combination of DWI and FLAIR findings can identify a subgroup of patients with M1 occlusion who are likely to benefit from recanalization. Indeed, the effect size for favorable outcome in recanalizers was much stronger (OR=16.2) in patients with than in those without FVH-DWI mismatch (OR=2.6), with a significant interaction between these variables. These results strengthen the notion that FVH located beyond the DWI cortical lesion boundaries reflect impaired yet viable tissue. When recanalization is achieved, this tissue restores its function, explaining why patients with FVH-DWI mismatch are more likely to reach favorable clinical outcome. Similar results have been shown using the PWI-DWI mismatch, with more favorable clinical outcomes in target mismatch patients who had early reperfusion after endovascular stroke treatment.1 We have previously reported an excellent (92%) sensitivity of the FVH-DWI mismatch to identify patients with large PWI-DWI mismatch, indicating that the former only rarely missed the latter.2
The benefit from recanalization (OR=7.0; 95% CI, 1.1–44.1; P=0.047) in patients without PWI-DWI mismatch was somewhat unexpected. Owing to a stringent and binary definition for the mismatch (here, as in DEFUSE 2,1 PWITmax>6sec/DWI=1.8), some patients in the no PWI-DWI mismatch group likely had a clinically meaningful amount of salvageable tissue, even if not large enough to be classified as mismatch positive.
There are several advantages of using the FLAIR-based mismatch model: it obviates the need for gadolinium contrast; it is easily assessable, reproducible,2 does not require any dedicated software, and does not expand the acquisition time because FLAIR is commonly used to rule-out stroke mimics and estimate stroke age.21 Other mismatch alternatives that do not require contrast injection include the clinical-DWI mismatch22 and the magnetic resonance angiography-DWI mismatch.23,24 However, both imply a volumetric analysis of the DWI lesion, which requires dedicated automated software or manual segmentation. Although untested to date, the FVH-DWI mismatch could be transposed to CT by replacing the FVH by a collateral CT score25 and use the CT-cerebral blood flow threshold <30% instead of DWI for the core.26 Finally, the FVH-DWI mismatch might be a predictor of smaller final infarct volume, even in patients who do not recanalize. However, this point is beyond the scope of the present study and should be investigated in larger cohorts, which would allow adjusting for initial DWI volume and other potential confounders.
Our study is retrospective and based on selected patients with M1 occlusion from a single center, with a sample size that limits the direct comparison of PWI- and FVH-DWI mismatch models after stratification on recanalization. We, however, previously compared the 2 methods using different Tmax thresholds2 and found that FVH-DWI was a reasonable surrogate to identify patients with large PWI-DWI mismatch. Finally, results might have been different had the stratification been based on early recanalization or reperfusion instead of 24-hours magnetic resonance angiography.
Conclusions
Because the FVH-DWI mismatch seems to identify patients most likely to benefit from recanalization, it may provide an alternative to PWI-DWI mismatch to select patients who are candidates for recanalization and enrich trial cohorts. Our results need to be validated in an external data set and tested in patients treated by thrombectomy or bridging therapy.
Supplemental Material
File (legrand_424.pdf)
- Download
- 279.37 KB
References
1.
Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al.; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860–867. doi: 10.1016/S1474-4422(12)70203-X.
2.
Legrand L, Tisserand M, Turc G, Naggara O, Edjlali M, Mellerio C, et al. Do FLAIR vascular hyperintensities beyond the DWI lesion represent the ischemic penumbra? AJNR Am J Neuroradiol. 2015;36:269–274. doi: 10.3174/ajnr.A4088.
3.
Azizyan A, Sanossian N, Mogensen MA, Liebeskind DS. Fluid-attenuated inversion recovery vascular hyperintensities: an important imaging marker for cerebrovascular disease. AJNR Am J Neuroradiol. 2011;32:1771–1775. doi: 10.3174/ajnr.A2265.
4.
Sanossian N, Saver JL, Alger JR, Kim D, Duckwiler GR, Jahan R, et al. Angiography reveals that fluid-attenuated inversion recovery vascular hyperintensities are due to slow flow, not thrombus. AJNR Am J Neuroradiol. 2009;30:564–568. doi: 10.3174/ajnr.A1388.
5.
Lee KY, Latour LL, Luby M, Hsia AW, Merino JG, Warach S. Distal hyperintense vessels on FLAIR: an MRI marker for collateral circulation in acute stroke? Neurology. 2009;72:1134–1139. doi: 10.1212/01.wnl.0000345360.80382.69.
6.
Huang X, Liu W, Zhu W, Ni G, Sun W, Ma M, et al. Distal hyperintense vessels on FLAIR: a prognostic indicator of acute ischemic stroke. Eur Neurol. 2012;68:214–220. doi: 10.1159/000340021.
7.
Olindo S, Chausson N, Joux J, Saint-Vil M, Signate A, Edimonana-Kapute M, et al. Fluid-attenuated inversion recovery vascular hyperintensity: an early predictor of clinical outcome in proximal middle cerebral artery occlusion. Arch Neurol. 2012;69:1462–1468. doi: 10.1001/archneurol.2012.1310.
8.
Perez de la Ossa N, Hernandez-Perez M, Domenech S, Cuadras P, Massuet A, Millan M, et al. Hyperintensity of distal vessels on FLAIR is associated with slow progression of the infarction in acute ischemic stroke. Cerebrovasc Dis. 2012;34:376–384.
9.
Girot M, Gauvrit JY, Cordonnier C, Pruvo JP, Verdelho A, Leys D, et al. Prognostic value of hyperintense vessel signals on fluid-attenuated inversion recovery sequences in acute cerebral ischemia. Eur Neurol. 2007;57:75–79. doi: 10.1159/000098055.
10.
Ebinger M, Kufner A, Galinovic I, Brunecker P, Malzahn U, Nolte CH, et al. Fluid-attenuated inversion recovery images and stroke outcome after thrombolysis. Stroke. 2012;43:539–542. doi: 10.1161/STROKEAHA.111.632026.
11.
Cheng B, Ebinger M, Kufner A, Köhrmann M, Wu O, Kang DW, et al.; Stroke Imaging Repository (STIR) Investigators. Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings. Stroke. 2012;43:2957–2961. doi: 10.1161/STROKEAHA.112.658906.
12.
Hohenhaus M, Schmidt WU, Brunecker P, Xu C, Hotter B, Rozanski M, et al. FLAIR vascular hyperintensities in acute ICA and MCA infarction: a marker for mismatch and stroke severity? Cerebrovasc Dis. 2012;34:63–69. doi: 10.1159/000339012.
13.
Schellinger PD, Chalela JA, Kang DW, Latour LL, Warach S. Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005;26:618–624.
14.
Kamran S, Bates V, Bakshi R, Wright P, Kinkel W, Miletich R. Significance of hyperintense vessels on FLAIR MRI in acute stroke. Neurology. 2000;55:265–269.
15.
Haussen DC, Koch S, Saraf-Lavi E, Shang T, Dharmadhikari S, Yavagal DR. FLAIR distal hyperintense vessels as a marker of perfusion-diffusion mismatch in acute stroke. J Neuroimaging. 2013;23:397–400. doi: 10.1111/j.1552-6569.2012.00784.x.
16.
Toyoda K, Ida M, Fukuda K. Fluid-attenuated inversion recovery intraarterial signal: an early sign of hyperacute cerebral ischemia. AJNR Am J Neuroradiol. 2001;22:1021–1029.
17.
Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke. 2011;42:693–699. doi: 10.1161/STROKEAHA.110.595256.
18.
Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke. 2012;43:2986–2991. doi: 10.1161/STROKEAHA.112.661009.
19.
Steyerberg EW.Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. New York, NY: Springer; 2009.
20.
Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503–1510.
21.
Petkova M, Rodrigo S, Lamy C, Oppenheim G, Touzé E, Mas JL, et al. MR imaging helps predict time from symptom onset in patients with acute stroke: implications for patients with unknown onset time. Radiology. 2010;257:782–792. doi: 10.1148/radiol.10100461.
22.
Dávalos A, Blanco M, Pedraza S, Leira R, Castellanos M, Pumar JM, et al. The clinical-DWI mismatch: a new diagnostic approach to the brain tissue at risk of infarction. Neurology. 2004;62:2187–2192.
23.
Lansberg MG, Thijs VN, Bammer R, Olivot JM, Marks MP, Wechsler LR, et al. The MRA-DWI mismatch identifies patients with stroke who are likely to benefit from reperfusion. Stroke. 2008;39:2491–2496. doi: 10.1161/STROKEAHA.107.508572.
24.
Mishra NK, Albers GW, Christensen S, Marks M, Hamilton S, Straka M, et al.; Diffusion and Perfusion Imaging Evaluation for Understanding Stroke Evolution 2 Investigators. Comparison of magnetic resonance imaging mismatch criteria to select patients for endovascular stroke therapy. Stroke. 2014;45:1369–1374. doi: 10.1161/STROKEAHA.114.004772.
25.
Goyal M, Demchuk AM, Menon BK, Eesa M, Rempel JL, Thornton J, et al.; ESCAPE Trial Investigators. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372:1019–1030. doi: 10.1056/NEJMoa1414905.
26.
Campbell BC, Christensen S, Levi CR, Desmond PM, Donnan GA, Davis SM, et al. Cerebral blood flow is the optimal CT perfusion parameter for assessing infarct core. Stroke. 2011;42:3435–3440. doi: 10.1161/STROKEAHA.111.618355.
Information & Authors
Information
Published In
Copyright
© 2016 American Heart Association, Inc.
Versions
You are viewing the most recent version of this article.
History
Received: 27 July 2015
Revision received: 5 November 2015
Accepted: 30 November 2015
Published online: 5 January 2016
Published in print: February 2016
Keywords
Subjects
Authors
Disclosures
None.
Sources of Funding
Laurence Legrand and Marie Tisserand are supported by the Société Française de Radiologie.
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- The association between FLAIR vascular hyperintensities and outcomes in patients with border zone infarcts treated with medical therapy may vary with the infarct subtype, Academic Radiology, (2024).https://doi.org/10.1016/j.acra.2024.09.019
- Effect of MR-guided perfusion imaging mismatch profiles within 6 h on endovascular thrombectomy outcomes, Neurological Sciences, (2024).https://doi.org/10.1007/s10072-024-07751-x
- Individualized interpretation for the clinical significance of fluid-attenuated inversion recovery vessel hyperintensity in ischemic stroke and transient ischemic attack: A systematic narrative review, European Journal of Radiology, 166, (111010), (2023).https://doi.org/10.1016/j.ejrad.2023.111010
- FLAIR vascular hyperintensity-DWI mismatch and DWI-FLAIR mismatch ASPECTS for prediction of good outcome after recanalization in anterior circulation stroke; multicenter observational study, European Journal of Radiology, 163, (110837), (2023).https://doi.org/10.1016/j.ejrad.2023.110837
- Clinical Applications of Diffusion, Functional Neuroradiology, (49-117), (2023).https://doi.org/10.1007/978-3-031-10909-6_4
- FLAIR Vascular Hyperintensities as a Surrogate of Collaterals in Acute Stroke: DWI Matters, American Journal of Neuroradiology, 44, 1, (26-32), (2022).https://doi.org/10.3174/ajnr.A7733
- Estimating Perfusion Deficits in Acute Stroke Patients Without Perfusion Imaging, Stroke, 53, 11, (3439-3445), (2022)./doi/10.1161/STROKEAHA.121.038101
- Association of fluid-attenuated inversion recovery vascular hyperintensity with ischaemic events in internal carotid artery or middle cerebral artery occlusion, Stroke and Vascular Neurology, 8, 1, (69-76), (2022).https://doi.org/10.1136/svn-2022-001589
- Hyperintense vessels on imaging account for neurological function independent of lesion volume in acute ischemic stroke, NeuroImage: Clinical, 34, (102991), (2022).https://doi.org/10.1016/j.nicl.2022.102991
- Prognostic value of post-treatment fluid-attenuated inversion recovery vascular hyperintensity in ischemic stroke after endovascular thrombectomy, European Radiology, 32, 12, (8067-8076), (2022).https://doi.org/10.1007/s00330-022-08886-1
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.